Skip to main content
Top
Published in: Sports Medicine 3/2001

01-03-2001 | Review Article

Chronic Fatigue Syndrome

An Update

Author: Professor Roy J. Shephard

Published in: Sports Medicine | Issue 3/2001

Login to get access

Abstract

The chronic fatigue syndrome is characterised by a fatigue that is disproportionate to the intensity of effort that is undertaken, has persisted for 6 months or longer, and has no obvious cause. Unless there has been a long period of patient- or physician- imposed inactivity, objective data may show little reduction in muscle strength or peak aerobic power, but the affected individual avoids heavy activity. The study of aetiology and treatment has been hampered by the low disease prevalence (probably <0.1% of the general population), and (until recently) by a lack of clear and standardised diagnostic criteria. It is unclear how far the aetiology is similar for athletes and nonathletes. It appears that in top competitors, overtraining and/or a negative energy balance can be precipitating factors. A wide variety of other possible causes and/or precipitating factors have been cited in the general population, including psychological stress, disorders of personality and affect, dysfunction of the hypothalamic-pituitary-adrenal axis, hormonal imbalance, nutritional deficits, immune suppression or activation and chronic infection. However, none of these factors have been observed consistently. The prognosis is poor; often disability and impairment of athletic performance are prolonged. Prevention of overtraining by careful monitoring seems the most effective approach in athletes. In those where the condition is established, treatment should aim at breaking the vicious cycle of effort avoidance, deterioration in physical condition and an increase in fatigue through a combination of encouragement and a progressive exercise programme.
Literature
1.
go back to reference Bock GR, Whalan J. Chronic fatigue syndrome. CIBA Foundation Symposium 173; 1992 May; London. Chichester: John Wiley, 1993 Bock GR, Whalan J. Chronic fatigue syndrome. CIBA Foundation Symposium 173; 1992 May; London. Chichester: John Wiley, 1993
2.
go back to reference Holmes GP, Kaplan JE, Schonberger LB, et al. Definition of the chronic fatigue syndrome [letter]. Ann Intern Med 1988; 109: 512–6 Holmes GP, Kaplan JE, Schonberger LB, et al. Definition of the chronic fatigue syndrome [letter]. Ann Intern Med 1988; 109: 512–6
3.
go back to reference Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl. 1: S8–S11PubMed Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl. 1: S8–S11PubMed
4.
go back to reference McCully KK, Sisto SA, Natelson BH. Use of exercise for treatment of chronic fatigue syndrome. Sports Med 1996; 21: 35–48PubMed McCully KK, Sisto SA, Natelson BH. Use of exercise for treatment of chronic fatigue syndrome. Sports Med 1996; 21: 35–48PubMed
5.
go back to reference Royal College of Physicians, Psychiatrists & General Practitioners. Chronic fatigue syndrome. London: Royal College of Physicians, Psychiatrists & General Practitioners, 1996 Royal College of Physicians, Psychiatrists & General Practitioners. Chronic fatigue syndrome. London: Royal College of Physicians, Psychiatrists & General Practitioners, 1996
6.
7.
go back to reference Kreider RB, Fry AC, O’Toole ML. Overtraining in sport. Champaign (IL): Human Kinetics Publishers, 1998 Kreider RB, Fry AC, O’Toole ML. Overtraining in sport. Champaign (IL): Human Kinetics Publishers, 1998
8.
go back to reference Verde T, Thomas S, Shephard RJ. Potential markers of heavy training in highly trained distance runners. Br J Sports Med 1992; 26: 167–75PubMed Verde T, Thomas S, Shephard RJ. Potential markers of heavy training in highly trained distance runners. Br J Sports Med 1992; 26: 167–75PubMed
9.
go back to reference Bailey DM, Davies B, Budgett R, et al. Recovery from infectious mononucleosis after altitude training in an elite middle distance runner. Br J Sports Med 1997; 31: 153–8PubMed Bailey DM, Davies B, Budgett R, et al. Recovery from infectious mononucleosis after altitude training in an elite middle distance runner. Br J Sports Med 1997; 31: 153–8PubMed
10.
go back to reference Mafulli N, Testa V, Capasso G. Post-viral fatigue syndrome: a longitudinal assessment in varsity athletes. J Sports Med Phys Fitness 1993; 33: 392–9 Mafulli N, Testa V, Capasso G. Post-viral fatigue syndrome: a longitudinal assessment in varsity athletes. J Sports Med Phys Fitness 1993; 33: 392–9
11.
go back to reference Rowbottom DG, Keast D, Green S, et al. The case history of an elite ultra-endurance athlete cyclist who developed chronic fatigue syndrome. Med Sci Sports Exerc 1998; 30: 1345–8PubMed Rowbottom DG, Keast D, Green S, et al. The case history of an elite ultra-endurance athlete cyclist who developed chronic fatigue syndrome. Med Sci Sports Exerc 1998; 30: 1345–8PubMed
12.
go back to reference Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate? Rev Infect Dis 1991; 13 Suppl. 1: S73–S83PubMed Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate? Rev Infect Dis 1991; 13 Suppl. 1: S73–S83PubMed
13.
go back to reference Zhang Q, Zhou XD, Denny T, et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 6–13PubMed Zhang Q, Zhou XD, Denny T, et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 6–13PubMed
14.
go back to reference Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res 1997; 31: 59–65PubMed Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res 1997; 31: 59–65PubMed
15.
go back to reference Glaser R, Kiecolt-Glaser JK. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105 Suppl. 3A: 35S-42S Glaser R, Kiecolt-Glaser JK. Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 1998; 105 Suppl. 3A: 35S-42S
16.
go back to reference Schluederberg A, Strauss SE, Peterson P, et al. NIH Conference: Chronic fatigue syndrome: definition and medical outcome assessment. Ann Intern Med 1992; 117: 325–31PubMed Schluederberg A, Strauss SE, Peterson P, et al. NIH Conference: Chronic fatigue syndrome: definition and medical outcome assessment. Ann Intern Med 1992; 117: 325–31PubMed
17.
go back to reference Friedberg F, Dechene L, McKenzie MJ, et al. Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res 2000; 48: 59–68PubMed Friedberg F, Dechene L, McKenzie MJ, et al. Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res 2000; 48: 59–68PubMed
18.
go back to reference Zhang QW, Natelson BH, Ottenweller JE, et al. Chronic fatigue syndrome beginning suddenly occurs seasonally over the year. Chronobiol Int 2000; 17: 95–9PubMed Zhang QW, Natelson BH, Ottenweller JE, et al. Chronic fatigue syndrome beginning suddenly occurs seasonally over the year. Chronobiol Int 2000; 17: 95–9PubMed
19.
go back to reference Klimas N, Salvato F, Morgan R, et al. Immunological abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–10PubMed Klimas N, Salvato F, Morgan R, et al. Immunological abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–10PubMed
20.
go back to reference Fry RW, Morton AR, Keast D. Overtraining syndrome and the chronic fatigue syndrome. N Z J Sports Med 1991; 19 (3):48–52 Fry RW, Morton AR, Keast D. Overtraining syndrome and the chronic fatigue syndrome. N Z J Sports Med 1991; 19 (3):48–52
21.
go back to reference Dickinson CJ. Chronic fatigue syndrome: aetiological aspects. Eur J Clin Invest 1997; 27: 257–67PubMed Dickinson CJ. Chronic fatigue syndrome: aetiological aspects. Eur J Clin Invest 1997; 27: 257–67PubMed
22.
go back to reference Evengard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Int Med 1999; 246: 455–69 Evengard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Int Med 1999; 246: 455–69
23.
go back to reference Goshorn RK. Chronic fatigue syndrome: a review for clinicians. Semin Neurol 1998; 18: 237–42PubMed Goshorn RK. Chronic fatigue syndrome: a review for clinicians. Semin Neurol 1998; 18: 237–42PubMed
24.
go back to reference Dawson DM, Sabin TD. Chronic fatigue syndrome. Boston (MA): Little, Brown, 1993 Dawson DM, Sabin TD. Chronic fatigue syndrome. Boston (MA): Little, Brown, 1993
25.
go back to reference Heyll U, Wachauf P, Senger V, et al. Definition of ‘chronic fatigue syndrome’ (CFS) [in German]. Med Klinik 1997; 92: 221–7 Heyll U, Wachauf P, Senger V, et al. Definition of ‘chronic fatigue syndrome’ (CFS) [in German]. Med Klinik 1997; 92: 221–7
26.
go back to reference Jain SS, DeLisa JA. Chronic fatigue syndrome: a literature review from a physiatric perspective. Am J Phys Med Rehabil 1998; 77: 160–7PubMed Jain SS, DeLisa JA. Chronic fatigue syndrome: a literature review from a physiatric perspective. Am J Phys Med Rehabil 1998; 77: 160–7PubMed
27.
go back to reference Johnson SK, DeLuca J, Natelson BH. Chronic fatigue syndrome: reviewing the research findings. Ann Behav Med 1999; 21: 258–71PubMed Johnson SK, DeLuca J, Natelson BH. Chronic fatigue syndrome: reviewing the research findings. Ann Behav Med 1999; 21: 258–71PubMed
28.
go back to reference Kakumanu S, Yeager M, Craig TJ. Chronic fatigue syndrome. J Am Osteopath Assoc 1999; 99 (10 Suppl. Pt 1): S1–S5PubMed Kakumanu S, Yeager M, Craig TJ. Chronic fatigue syndrome. J Am Osteopath Assoc 1999; 99 (10 Suppl. Pt 1): S1–S5PubMed
29.
go back to reference Marshall GS. Report of a workshop on the epidemiology, natural history, and pathogenesis of chronic fatigue syndrome in adolescents. J Pediatr 1999; 134: 395–405PubMed Marshall GS. Report of a workshop on the epidemiology, natural history, and pathogenesis of chronic fatigue syndrome in adolescents. J Pediatr 1999; 134: 395–405PubMed
30.
go back to reference Wessely S. Chronic fatigue syndrome: a 20th century illness. Scand J Work Environ Health 1997; 23 Suppl. 3: 17–34PubMed Wessely S. Chronic fatigue syndrome: a 20th century illness. Scand J Work Environ Health 1997; 23 Suppl. 3: 17–34PubMed
31.
go back to reference Joyce J, Rabe-Hesketh S, Wessely S. Reviewing the reviews: the example of chronic fatigue syndrome. JAMA 1998; 280: 264–6PubMed Joyce J, Rabe-Hesketh S, Wessely S. Reviewing the reviews: the example of chronic fatigue syndrome. JAMA 1998; 280: 264–6PubMed
32.
go back to reference van der Meer JW. Chronic fatigue syndrome [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1507–9PubMed van der Meer JW. Chronic fatigue syndrome [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1507–9PubMed
33.
go back to reference Fuller NS, Morrison RE. Chronic fatigue syndrome: helping patients cope with this enigmatic illness. Postgrad Med 1998; 103: 179–84 Fuller NS, Morrison RE. Chronic fatigue syndrome: helping patients cope with this enigmatic illness. Postgrad Med 1998; 103: 179–84
34.
go back to reference Nisenbaum R, Reyes M, Mawle AC, et al. Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome. Am J Epidemiol 1998; 148: 72–7PubMed Nisenbaum R, Reyes M, Mawle AC, et al. Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome. Am J Epidemiol 1998; 148: 72–7PubMed
35.
go back to reference Fry RW, Morton AR, Keast DW. Overtraining in athletes: an update. Sports Med 1991; 12: 32–65PubMed Fry RW, Morton AR, Keast DW. Overtraining in athletes: an update. Sports Med 1991; 12: 32–65PubMed
36.
go back to reference Derman W, Schwellnus MP, Lambert MI, et al. The ‘worn-out’ athlete: a clinical approach to chronic fatigue in athletes. J Sports Sci 1997; 15: 341–51PubMed Derman W, Schwellnus MP, Lambert MI, et al. The ‘worn-out’ athlete: a clinical approach to chronic fatigue in athletes. J Sports Sci 1997; 15: 341–51PubMed
37.
go back to reference Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Int Med 2000; 160: 221–7 Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Int Med 2000; 160: 221–7
38.
go back to reference Breau LM, McGrath PJ, Ju LH. Review of juvenile primary fibromyalgia and chronic fatigue syndrome. J Dev Behav Pediatr 1999; 20: 278–88PubMed Breau LM, McGrath PJ, Ju LH. Review of juvenile primary fibromyalgia and chronic fatigue syndrome. J Dev Behav Pediatr 1999; 20: 278–88PubMed
39.
go back to reference White KP, Speechley M, Harth M, et al. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population: a controlled study. Scand J Rheumatol 2000; 29:44–51PubMed White KP, Speechley M, Harth M, et al. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population: a controlled study. Scand J Rheumatol 2000; 29:44–51PubMed
40.
go back to reference Evengard B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia: no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998; 78: 153–5PubMed Evengard B, Nilsson CG, Lindh G, et al. Chronic fatigue syndrome differs from fibromyalgia: no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998; 78: 153–5PubMed
41.
go back to reference Sharpe M, Archard L, Bantavala J, et al. Chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118–21PubMed Sharpe M, Archard L, Bantavala J, et al. Chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118–21PubMed
42.
go back to reference Fukuda K, Straus SE, Hickie I, et al. Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953–8PubMed Fukuda K, Straus SE, Hickie I, et al. Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953–8PubMed
43.
go back to reference Jason LA, Richman JA, Friedberg F, et al. Politics, science, and the emergence of a new disease: the case of chronic fatigue syndrome. Am Psychol 1998; 52: 973–83 Jason LA, Richman JA, Friedberg F, et al. Politics, science, and the emergence of a new disease: the case of chronic fatigue syndrome. Am Psychol 1998; 52: 973–83
44.
go back to reference Arpino C, Carrieri MP, Valesini G, et al. Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann Ist Super Sanita 1999; 35: 435–41PubMed Arpino C, Carrieri MP, Valesini G, et al. Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann Ist Super Sanita 1999; 35: 435–41PubMed
45.
go back to reference Kawakami N, Iwata N, Fujihara S, et al. Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 1998; 186: 33–41PubMed Kawakami N, Iwata N, Fujihara S, et al. Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 1998; 186: 33–41PubMed
46.
go back to reference Levine PH. Epidemiological advances in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 7–18PubMed Levine PH. Epidemiological advances in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 7–18PubMed
47.
go back to reference Steele L, Dobbins JG, Fukuda K, et al. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998; 105 (3A): 83S-90S Steele L, Dobbins JG, Fukuda K, et al. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998; 105 (3A): 83S-90S
48.
go back to reference Chester AC. Chronic fatigue syndrome criteria in patients with other forms of unexplained chronic fatigue. J Psychiatr Res 1997; 31: 45–50PubMed Chester AC. Chronic fatigue syndrome criteria in patients with other forms of unexplained chronic fatigue. J Psychiatr Res 1997; 31: 45–50PubMed
49.
go back to reference Lee S, Yu H, Wing Y, et al. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatr 2000; 157: 380–4PubMed Lee S, Yu H, Wing Y, et al. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatr 2000; 157: 380–4PubMed
50.
go back to reference Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch Int Med 1999; 159:2129–37 Jason LA, Richman JA, Rademaker AW et al. A community-based study of chronic fatigue syndrome. Arch Int Med 1999; 159:2129–37
51.
go back to reference Versluis RG, de Waal MW, Opmeer C, et al. Prevalence of chronic fatigue in 4 family practices in Leiden [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1523–6PubMed Versluis RG, de Waal MW, Opmeer C, et al. Prevalence of chronic fatigue in 4 family practices in Leiden [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1523–6PubMed
52.
go back to reference Bazelmans E, Vercoulen JH, Galama JM, et al. Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in the Netherlands [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1520–3PubMed Bazelmans E, Vercoulen JH, Galama JM, et al. Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in the Netherlands [in Dutch]. Ned Tijdschr Geneeskd 1997; 141: 1520–3PubMed
53.
go back to reference Pagani M, Lucini D. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system. Clin Sci 1999; 96: 117–25PubMed Pagani M, Lucini D. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system. Clin Sci 1999; 96: 117–25PubMed
54.
go back to reference Jason LA, Wagner L, Rosenthal S, et al. Estimating the prevalence of chronic fatigue syndrome among nurses. Am J Med 1998; 105 (3A): 91S-93S Jason LA, Wagner L, Rosenthal S, et al. Estimating the prevalence of chronic fatigue syndrome among nurses. Am J Med 1998; 105 (3A): 91S-93S
55.
go back to reference Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449–55PubMed Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449–55PubMed
56.
go back to reference Vercoulen H, Swanink CM, Galama JM, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507–17PubMed Vercoulen H, Swanink CM, Galama JM, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507–17PubMed
57.
go back to reference Vercoulen JH, Bazelmans E, Swanink CM, et al. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 1997; 31: 661–73PubMed Vercoulen JH, Bazelmans E, Swanink CM, et al. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 1997; 31: 661–73PubMed
58.
go back to reference Clapp LL, Richardson MT, Smith JF, et al. Acute effects of thirty minutes of light-intensity, intermittent exercise on patients with chronic fatigue syndrome. Phys Ther 1999; 79:749–56PubMed Clapp LL, Richardson MT, Smith JF, et al. Acute effects of thirty minutes of light-intensity, intermittent exercise on patients with chronic fatigue syndrome. Phys Ther 1999; 79:749–56PubMed
59.
go back to reference Mullis R, Campbell IT, Wearden AJ, et al. Prediction of peak oxygen uptake in chronic fatigue syndrome. Br J Sports Med 1999; 33: 352–6PubMed Mullis R, Campbell IT, Wearden AJ, et al. Prediction of peak oxygen uptake in chronic fatigue syndrome. Br J Sports Med 1999; 33: 352–6PubMed
60.
go back to reference Sisto SA, Tapp WN, LaManca JJ, et al. Physical activity before and after exercise in women with chronic fatigue syndrome. Q J Med 1998; 91: 465–73 Sisto SA, Tapp WN, LaManca JJ, et al. Physical activity before and after exercise in women with chronic fatigue syndrome. Q J Med 1998; 91: 465–73
61.
go back to reference Lloyd A, Gandevia S, Hale J. Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain 1991; 114:85–98PubMed Lloyd A, Gandevia S, Hale J. Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome. Brain 1991; 114:85–98PubMed
62.
go back to reference Stokes MJ, Cooper RG, Edwards RH. Normal muscle strength and fatigability in patients with effort syndrome. BMJ 1988; 297:1014–17PubMed Stokes MJ, Cooper RG, Edwards RH. Normal muscle strength and fatigability in patients with effort syndrome. BMJ 1988; 297:1014–17PubMed
63.
go back to reference De Lorenzo F, Xiao H, Mukherjee M, et al. Chronic fatigue syndrome: physical and cardiovascular deconditioning. Q J Med 1998; 91: 475–81 De Lorenzo F, Xiao H, Mukherjee M, et al. Chronic fatigue syndrome: physical and cardiovascular deconditioning. Q J Med 1998; 91: 475–81
64.
go back to reference Peterson PK, Sirr S, Grammith FC, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immunol 1994; 1: 222–6PubMed Peterson PK, Sirr S, Grammith FC, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immunol 1994; 1: 222–6PubMed
65.
go back to reference Lloyd A, Gandevia S, Brockman A, et al. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 18 Suppl.: S142–S146 Lloyd A, Gandevia S, Brockman A, et al. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 18 Suppl.: S142–S146
66.
go back to reference Saggini R, Pizzigallo E, Vecchiet J, et al. Alteration of spatial-temporal parameters of gait in chronic fatigue syndrome patients. J Neurol Sci 1998; 154: 18–25PubMed Saggini R, Pizzigallo E, Vecchiet J, et al. Alteration of spatial-temporal parameters of gait in chronic fatigue syndrome patients. J Neurol Sci 1998; 154: 18–25PubMed
67.
go back to reference Gordon R, Michalewski HJ, Nguyen T, et al. Cortical motor potential alterations in chronic fatigue syndrome. Int J Mol Med 1999; 4: 493–9PubMed Gordon R, Michalewski HJ, Nguyen T, et al. Cortical motor potential alterations in chronic fatigue syndrome. Int J Mol Med 1999; 4: 493–9PubMed
68.
go back to reference LaManca JJ, Sisto SA, DeLuca J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am J Med 1998; 105 (3A): 598–658 LaManca JJ, Sisto SA, DeLuca J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am J Med 1998; 105 (3A): 598–658
69.
go back to reference Marshall PS, Forstot M, Callies A, et al. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med 1997; 59: 58–66PubMed Marshall PS, Forstot M, Callies A, et al. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med 1997; 59: 58–66PubMed
70.
go back to reference Block W, Traber F, Kuhl CK, et al. 31P-mr spectroscopy of peripheral skeletal musculature under load: demonstration of normal energy metabolism compared with metabolic muscle diseases [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgen Verfahr 1998; 168: 250–7 Block W, Traber F, Kuhl CK, et al. 31P-mr spectroscopy of peripheral skeletal musculature under load: demonstration of normal energy metabolism compared with metabolic muscle diseases [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgen Verfahr 1998; 168: 250–7
71.
go back to reference McCully KK, Natelson BH. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci 1999; 97: 611–3 McCully KK, Natelson BH. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci 1999; 97: 611–3
72.
go back to reference Lane RJ, Barrett MC, Taylor DJ, et al. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscular Disord 1998; 8: 204–9 Lane RJ, Barrett MC, Taylor DJ, et al. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscular Disord 1998; 8: 204–9
73.
go back to reference Lane RJ, Barrett MC, Woodrow D, et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1998; 64: 362–7PubMed Lane RJ, Barrett MC, Woodrow D, et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1998; 64: 362–7PubMed
74.
go back to reference Sisto SA, LaManca J, Cordero DL, et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med 1996; 100: 634–40PubMed Sisto SA, LaManca J, Cordero DL, et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med 1996; 100: 634–40PubMed
75.
go back to reference Blackwood SK, MacHale SM, Power MJ, et al. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatr 1998; 65: 541–6PubMed Blackwood SK, MacHale SM, Power MJ, et al. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatr 1998; 65: 541–6PubMed
76.
go back to reference Fischler B, Dendale P, Michiels V, et al. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res 1997; 42: 369–78PubMed Fischler B, Dendale P, Michiels V, et al. Physical fatigability and exercise capacity in chronic fatigue syndrome: association with disability, somatization and psychopathology. J Psychosom Res 1997; 42: 369–78PubMed
77.
go back to reference Wood B, Wessely S. Personality and social attitudes in chronic fatigue syndrome. J Psychosom Res 1999; 47: 385–97PubMed Wood B, Wessely S. Personality and social attitudes in chronic fatigue syndrome. J Psychosom Res 1999; 47: 385–97PubMed
78.
go back to reference Blenkiron P, Edwards R, Lynch S. Associations between perfectionism, mood and fatigue in chronic fatigue syndrome: a pilot study. J Nerv Ment Dis 1999; 187: 566–70PubMed Blenkiron P, Edwards R, Lynch S. Associations between perfectionism, mood and fatigue in chronic fatigue syndrome: a pilot study. J Nerv Ment Dis 1999; 187: 566–70PubMed
79.
go back to reference Buckley L, MacHale SM, Cavanagh JT, et al. Personality dimensions in chronic fatigue syndrome and depression. J Psychosom Res 1999; 46: 395–400PubMed Buckley L, MacHale SM, Cavanagh JT, et al. Personality dimensions in chronic fatigue syndrome and depression. J Psychosom Res 1999; 46: 395–400PubMed
80.
go back to reference Christodoulou C, Deluca J, Johnson SK, et al. Examination of Cloninger’s basic dimensions of personality in fatiguing illness: chronic fatigue syndrome and multiple sclerosis. J Psychosom Res 1999; 47: 597–607PubMed Christodoulou C, Deluca J, Johnson SK, et al. Examination of Cloninger’s basic dimensions of personality in fatiguing illness: chronic fatigue syndrome and multiple sclerosis. J Psychosom Res 1999; 47: 597–607PubMed
81.
go back to reference Deale A, Chalder T, Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res 1998; 45 (1 Spec No.): 77–83PubMed Deale A, Chalder T, Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res 1998; 45 (1 Spec No.): 77–83PubMed
82.
go back to reference Ray C, Jefferies S, Weir WR. Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J Psychosom Res 1997; 43: 405–15PubMed Ray C, Jefferies S, Weir WR. Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J Psychosom Res 1997; 43: 405–15PubMed
83.
go back to reference Brunello N, Akiskal H, Boyer P, et al. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacologic considerations, and new therapeutic vistas. J Affect Disord 1999; 52: 275–90PubMed Brunello N, Akiskal H, Boyer P, et al. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacologic considerations, and new therapeutic vistas. J Affect Disord 1999; 52: 275–90PubMed
84.
go back to reference Findley JC, Kerns R, Weinberg LD, et al. Self-efficacy as a psychological moderator of chronic fatigue syndrome. J Behav Med 1998; 21: 351–62PubMed Findley JC, Kerns R, Weinberg LD, et al. Self-efficacy as a psychological moderator of chronic fatigue syndrome. J Behav Med 1998; 21: 351–62PubMed
85.
go back to reference DeLuca J, Johnson SK, Ellis SP, et al. Sudden vs. gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J Psychiatr Res 1997; 31: 83–90PubMed DeLuca J, Johnson SK, Ellis SP, et al. Sudden vs. gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. J Psychiatr Res 1997; 31: 83–90PubMed
86.
go back to reference Morriss RK, Ahmed M, Wearden AJ, et al. The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 1999; 55: 143–8PubMed Morriss RK, Ahmed M, Wearden AJ, et al. The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 1999; 55: 143–8PubMed
87.
go back to reference American Psychological Association. Diagnostic and Statistical Manual of Mental Diseases (DSM-III-R). 3rd rev. ed. Washington, DC: American Psychological Association, 1987 American Psychological Association. Diagnostic and Statistical Manual of Mental Diseases (DSM-III-R). 3rd rev. ed. Washington, DC: American Psychological Association, 1987
88.
go back to reference Fischler B, Cluydts R, De Gucht Y, et al. Generalized anxiety disorder in chronic fatigue syndrome. Acta Psychiatr Scand 1997; 95: 405–13PubMed Fischler B, Cluydts R, De Gucht Y, et al. Generalized anxiety disorder in chronic fatigue syndrome. Acta Psychiatr Scand 1997; 95: 405–13PubMed
89.
go back to reference Garralda E, Rangel L, Levin M, et al. Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatr 1999; 38: 1515–21 Garralda E, Rangel L, Levin M, et al. Psychiatric adjustment in adolescents with a history of chronic fatigue syndrome. J Am Acad Child Adolesc Psychiatr 1999; 38: 1515–21
90.
go back to reference Terman M, Levine SM, Terman JS, et al. Chronic fatigue syndrome and seasonal affective disorder: comorbidity, diagnostic overlap, and implications for treatment. Am J Med 1998; 105 (3A): 115S-24S Terman M, Levine SM, Terman JS, et al. Chronic fatigue syndrome and seasonal affective disorder: comorbidity, diagnostic overlap, and implications for treatment. Am J Med 1998; 105 (3A): 115S-24S
91.
go back to reference van der Linden G, Chalder T, Hickie I, et al. Fatigue and psychiatric disorder: different or the same? Psychol Med 1999; 29: 863–8PubMed van der Linden G, Chalder T, Hickie I, et al. Fatigue and psychiatric disorder: different or the same? Psychol Med 1999; 29: 863–8PubMed
92.
go back to reference Koschera A, Hickie I, Hadzi-Pavlovic D, et al. Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Austr N Z J Psychiatr 1999; 33: 545–52 Koschera A, Hickie I, Hadzi-Pavlovic D, et al. Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Austr N Z J Psychiatr 1999; 33: 545–52
93.
go back to reference Theorell T, Blomkvist V, Lindh G, et al. Critical life events, infections and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999; 61: 304–10PubMed Theorell T, Blomkvist V, Lindh G, et al. Critical life events, infections and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999; 61: 304–10PubMed
94.
go back to reference Vollmer-Conna U, Wakefield D, Lloyd A, et al. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br J Psychiatr 1997; 171: 377–81 Vollmer-Conna U, Wakefield D, Lloyd A, et al. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br J Psychiatr 1997; 171: 377–81
95.
go back to reference DeLuca J, Johnson SK, Ellis SP, et al. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatr 1997; 62: 151–5PubMed DeLuca J, Johnson SK, Ellis SP, et al. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatr 1997; 62: 151–5PubMed
96.
go back to reference Christodoulou C, DeLuca J, Lange G, et al. Relation between neuropsychological impairment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1998; 64: 431–4PubMed Christodoulou C, DeLuca J, Lange G, et al. Relation between neuropsychological impairment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1998; 64: 431–4PubMed
97.
go back to reference Smith AP, Borysiewicz L, PollockJ, et al. Acute fatigue in chronic fatigue syndrome patients. Psychol Med 1999; 29: 283–90PubMed Smith AP, Borysiewicz L, PollockJ, et al. Acute fatigue in chronic fatigue syndrome patients. Psychol Med 1999; 29: 283–90PubMed
98.
go back to reference Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome. J Int Neuropsychol See 1998; 4: 456–66 Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome. J Int Neuropsychol See 1998; 4: 456–66
99.
go back to reference Servatius RJ, Tapp WN, Bergen MT, et al. Impaired associative learning in chronic fatigue syndrome. Neuroreport 1998; 9: 1153–7PubMed Servatius RJ, Tapp WN, Bergen MT, et al. Impaired associative learning in chronic fatigue syndrome. Neuroreport 1998; 9: 1153–7PubMed
100.
go back to reference Tiersky LA, Johnson SK, Lamge G, et al. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol 1997; 19: 560–86PubMed Tiersky LA, Johnson SK, Lamge G, et al. Neuropsychology of chronic fatigue syndrome: a critical review. J Clin Exp Neuropsychol 1997; 19: 560–86PubMed
101.
go back to reference Vercoulen JH, Bazelmans E, Swanink CM, et al. Evaluating neuropsychologic impairment in chronic fatigue syndrome. J Clin Exp Neuropsychol 1998; 20: 144–56PubMed Vercoulen JH, Bazelmans E, Swanink CM, et al. Evaluating neuropsychologic impairment in chronic fatigue syndrome. J Clin Exp Neuropsychol 1998; 20: 144–56PubMed
102.
go back to reference Kane RL, Gantz NM, DiPino RK. Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatr Neuropsychol Behav Neurol 1997; 10: 25–31 Kane RL, Gantz NM, DiPino RK. Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatr Neuropsychol Behav Neurol 1997; 10: 25–31
103.
go back to reference Wearden A, Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome. Psychol Med 1997; 27: 81–90PubMed Wearden A, Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome. Psychol Med 1997; 27: 81–90PubMed
104.
go back to reference Michiels V, de Gucht V, Cluydts R, et al. Attention and information processing efficiency in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol 1999; 21: 709–29PubMed Michiels V, de Gucht V, Cluydts R, et al. Attention and information processing efficiency in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol 1999; 21: 709–29PubMed
105.
go back to reference Bompa T. Theory and methodology of training. Dubuque (IA): Kendall/Hunt Publishing, 1983 Bompa T. Theory and methodology of training. Dubuque (IA): Kendall/Hunt Publishing, 1983
106.
go back to reference Kindermann W. Overtraining: an expression of faulty regulated development. Dtsche Z Sportmed 1986; 37: 238–45 Kindermann W. Overtraining: an expression of faulty regulated development. Dtsche Z Sportmed 1986; 37: 238–45
107.
go back to reference Lehmann M, Foster C, Netzer N, et al. Physiological responses to short- and long-term overtraining in endurance athletes. In: Kreider RB, Fry AC, O’Toole ML, editors. Overtraining in Sport. Champaign (IL): Human Kinetics, 1998: 19–46 Lehmann M, Foster C, Netzer N, et al. Physiological responses to short- and long-term overtraining in endurance athletes. In: Kreider RB, Fry AC, O’Toole ML, editors. Overtraining in Sport. Champaign (IL): Human Kinetics, 1998: 19–46
108.
go back to reference Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 357–64PubMed Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 357–64PubMed
109.
go back to reference Smit AA, Bolweg NM, Lenders JW, et al. No strong evidence of disturbed regulation of blood pressure in chronic fatigue syndrome. Ned Tijdschr Geneeskd 1998; 142: 625–8PubMed Smit AA, Bolweg NM, Lenders JW, et al. No strong evidence of disturbed regulation of blood pressure in chronic fatigue syndrome. Ned Tijdschr Geneeskd 1998; 142: 625–8PubMed
110.
go back to reference Soetekouw PM, Lenders JW, Bleijenberg G, et al. Autonomic function in patients with chronic fatigue syndrome. Clin Auton Res 1999; 9: 334–40PubMed Soetekouw PM, Lenders JW, Bleijenberg G, et al. Autonomic function in patients with chronic fatigue syndrome. Clin Auton Res 1999; 9: 334–40PubMed
111.
go back to reference Shephard RJ. Exercise and relaxation in health promotion. Sports Med 1997; 23: 211–7PubMed Shephard RJ. Exercise and relaxation in health promotion. Sports Med 1997; 23: 211–7PubMed
112.
go back to reference De Becker P, Dendale P, De Meirleir K, et al. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998; 105 (3A): 22S-6S De Becker P, Dendale P, De Meirleir K, et al. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998; 105 (3A): 22S-6S
113.
go back to reference Duprez DA, De Buyzere ML, Drieghe B, et al. Long- and short-term blood pressure and R-R interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci 1999; 94: 57–63 Duprez DA, De Buyzere ML, Drieghe B, et al. Long- and short-term blood pressure and R-R interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci 1999; 94: 57–63
114.
go back to reference Yataco A, Talo H, Rowe P, et al. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin Auton Res 1997; 7: 293–7PubMed Yataco A, Talo H, Rowe P, et al. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin Auton Res 1997; 7: 293–7PubMed
115.
go back to reference Streeten DH, Anderson GH. The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res 1998; 8: 119–24PubMed Streeten DH, Anderson GH. The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res 1998; 8: 119–24PubMed
116.
go back to reference Schondorf R, Freeman R. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999; 317: 117–23PubMed Schondorf R, Freeman R. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999; 317: 117–23PubMed
117.
go back to reference Rowe PC, Calkins H. Neurally-mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105 (3A): 15S-21S Rowe PC, Calkins H. Neurally-mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105 (3A): 15S-21S
118.
go back to reference Wilke WS, Fouad-Tarazi FM, Cash JM, et al. The connection between chronic fatigue syndrome and neurally mediated hypotension. Cleve Clin J Med 1998; 65: 261–6PubMed Wilke WS, Fouad-Tarazi FM, Cash JM, et al. The connection between chronic fatigue syndrome and neurally mediated hypotension. Cleve Clin J Med 1998; 65: 261–6PubMed
119.
go back to reference Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1–10 Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1–10
120.
go back to reference Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997; 31: 69–82PubMed Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997; 31: 69–82PubMed
121.
go back to reference Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998; 840: 684–97PubMed Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998; 840: 684–97PubMed
122.
go back to reference Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos Syndrome. J Pediatr 1999; 135: 494–9PubMed Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos Syndrome. J Pediatr 1999; 135: 494–9PubMed
123.
go back to reference van de Luit L, van der Meulen J, Cleophas TJ, et al. Amplified amplitude of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiol 1998; 49: 903–8 van de Luit L, van der Meulen J, Cleophas TJ, et al. Amplified amplitude of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiol 1998; 49: 903–8
124.
go back to reference Stewart JM, Gewitz MH, Weldon A, et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999; 135: 218–25PubMed Stewart JM, Gewitz MH, Weldon A, et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999; 135: 218–25PubMed
125.
go back to reference Stewart JM, Gewitz MH, Weldon A, et al. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999; 103: 116–21PubMed Stewart JM, Gewitz MH, Weldon A, et al. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999; 103: 116–21PubMed
126.
go back to reference LaManca JJ, Peckerman A, Walker J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999; 19: 111–20PubMed LaManca JJ, Peckerman A, Walker J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999; 19: 111–20PubMed
127.
go back to reference Schondorf R, Benoit J, Wein T, et al. Orthostatic intolerance in the chronic fatigue syndrome. J Auton New Syst 1999; 75: 192–201 Schondorf R, Benoit J, Wein T, et al. Orthostatic intolerance in the chronic fatigue syndrome. J Auton New Syst 1999; 75: 192–201
128.
go back to reference De Lorenzo F, Hargreaves J, Kakkar VV. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin Auton Res 1997; 7: 185–90PubMed De Lorenzo F, Hargreaves J, Kakkar VV. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin Auton Res 1997; 7: 185–90PubMed
129.
go back to reference Shephard RJ. Physiology and biochemistry of exercise. New York (NY): Praeger Publications, 1982 Shephard RJ. Physiology and biochemistry of exercise. New York (NY): Praeger Publications, 1982
130.
go back to reference Peroutka SJ. Chronic fatigue disorders: an inappropriate response to arginine vasopressin? Med Hypotheses 1998; 50: 521–3PubMed Peroutka SJ. Chronic fatigue disorders: an inappropriate response to arginine vasopressin? Med Hypotheses 1998; 50: 521–3PubMed
131.
go back to reference Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25:1–35PubMed Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25:1–35PubMed
132.
go back to reference Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to cortico-tropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450–7PubMed Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to cortico-tropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450–7PubMed
133.
go back to reference Scott LV, Burnett F, Medbak S, et al. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998; 28: 285–93PubMed Scott LV, Burnett F, Medbak S, et al. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998; 28: 285–93PubMed
134.
go back to reference Dinan TG, Majeed T, Lavelle E, et al. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997; 22: 261–7PubMed Dinan TG, Majeed T, Lavelle E, et al. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997; 22: 261–7PubMed
135.
go back to reference Strickland P, Morriss R, Wearden A, et al. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 1998; 47: 191–4PubMed Strickland P, Morriss R, Wearden A, et al. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 1998; 47: 191–4PubMed
136.
go back to reference Wood B, Wessely S, Papadopoulos A, et al. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 1998; 37: 1–4PubMed Wood B, Wessely S, Papadopoulos A, et al. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 1998; 37: 1–4PubMed
137.
go back to reference Scott LV, Teh J, Reznek R, et al. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999;24:759–68PubMed Scott LV, Teh J, Reznek R, et al. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999;24:759–68PubMed
138.
go back to reference Sterzl I, Fucikova T, Hrda P, et al. The fatigue syndrome in autoimmune thyroiditis with polyglandular activation of autoimmunity. Vnitrni Lekarstvi 1998; 44: 456–60PubMed Sterzl I, Fucikova T, Hrda P, et al. The fatigue syndrome in autoimmune thyroiditis with polyglandular activation of autoimmunity. Vnitrni Lekarstvi 1998; 44: 456–60PubMed
139.
go back to reference Kuratsune H, Yamaguti K, Sawada M, et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998; 1: 143–6PubMed Kuratsune H, Yamaguti K, Sawada M, et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1998; 1: 143–6PubMed
140.
go back to reference Scott LV, Salahuddin F, Cooney J, et al. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 1999; 54: 129–37PubMed Scott LV, Salahuddin F, Cooney J, et al. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord 1999; 54: 129–37PubMed
141.
go back to reference De Becker P, De Meirleir K, Joos E, et al. Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm Metabol Res 1999; 31: 18–21 De Becker P, De Meirleir K, Joos E, et al. Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome. Horm Metabol Res 1999; 31: 18–21
142.
go back to reference Harlow BL, Signorello LB, Hall JE, et al. Reproductive correlates of chronic fatigue syndrome. Am J Med 1998; 105 (3A): 94S-9S Harlow BL, Signorello LB, Hall JE, et al. Reproductive correlates of chronic fatigue syndrome. Am J Med 1998; 105 (3A): 94S-9S
143.
go back to reference Panay N, Studd JW. The psychotherapeutic effect of estrogens. Gynecol Endocrinol 1998; 12: 353–65PubMed Panay N, Studd JW. The psychotherapeutic effect of estrogens. Gynecol Endocrinol 1998; 12: 353–65PubMed
144.
go back to reference Bennett AL, Mayes DM, Fagioloi LR, et al. Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndrome. J Psychiatr Res 1997; 31: 91–6PubMed Bennett AL, Mayes DM, Fagioloi LR, et al. Somatomedin C (insulin-like growth factor I) levels in patients with chronic fatigue syndrome. J Psychiatr Res 1997; 31: 91–6PubMed
145.
go back to reference Allain TJ, Bearn JA, Coskeran P, et al. Changes in growth hormone, insulin, insulin like growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatr 1997; 41: 567–73 Allain TJ, Bearn JA, Coskeran P, et al. Changes in growth hormone, insulin, insulin like growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatr 1997; 41: 567–73
146.
go back to reference Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 138: 32 Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 138: 32
147.
go back to reference Shephard RJ. Fitness and health in industry. Basel: S. Karger, 1986 Shephard RJ. Fitness and health in industry. Basel: S. Karger, 1986
148.
go back to reference Hooper SL, Mackinnon LT, Howard A, et al. Markers for monitoring over-training and recovery. Med Sci Sports Exerc 1995; 27: 106–12PubMed Hooper SL, Mackinnon LT, Howard A, et al. Markers for monitoring over-training and recovery. Med Sci Sports Exerc 1995; 27: 106–12PubMed
149.
go back to reference O’Connor PJ, Morgan WP, Raglin JS, et al. Mood state and salivary cortisol levels following overtraining in female swimmers. Psychoneuroendocrinology 1989; 14: 303–10PubMed O’Connor PJ, Morgan WP, Raglin JS, et al. Mood state and salivary cortisol levels following overtraining in female swimmers. Psychoneuroendocrinology 1989; 14: 303–10PubMed
150.
go back to reference Scott LV, Dinan TG. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998; 47: 49–54PubMed Scott LV, Dinan TG. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998; 47: 49–54PubMed
151.
go back to reference Young AH, Sharpe M, Clements A, et al. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatr 1998; 43: 236–7 Young AH, Sharpe M, Clements A, et al. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatr 1998; 43: 236–7
152.
go back to reference MacHale SM, Cavanagh JT, Bennie J, et al. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998;38: 213–7PubMed MacHale SM, Cavanagh JT, Bennie J, et al. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998;38: 213–7PubMed
153.
go back to reference Handles DL, Nutter D, Gershtenson J, et al. Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatr 1998; 43: 293–302 Handles DL, Nutter D, Gershtenson J, et al. Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatr 1998; 43: 293–302
154.
go back to reference Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet 1999; 353: 455–8PubMed Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet 1999; 353: 455–8PubMed
155.
go back to reference McKenzie R, O’Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998; 280: 1061–6PubMed McKenzie R, O’Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998; 280: 1061–6PubMed
156.
go back to reference Prior J-L. Exercise-related adaptations and the health of men and women. In: Bouchard C, Shephard RJ, Stephens T, et al., editors. Exercise, fitness and health. Champaign (IL): Human Kinetics, 1990: 661–75 Prior J-L. Exercise-related adaptations and the health of men and women. In: Bouchard C, Shephard RJ, Stephens T, et al., editors. Exercise, fitness and health. Champaign (IL): Human Kinetics, 1990: 661–75
157.
go back to reference Aakvaag A. Hormonal changes in serum in young men during prolonged physical strain. Eur J Appl Physiol 1978; 39: 283–91 Aakvaag A. Hormonal changes in serum in young men during prolonged physical strain. Eur J Appl Physiol 1978; 39: 283–91
158.
go back to reference Urhausen A. Behaviour of testosterone, SHBG, and cortisol before and after a triathlon competition. Int J Sports Med 1987; 8: 305–8PubMed Urhausen A. Behaviour of testosterone, SHBG, and cortisol before and after a triathlon competition. Int J Sports Med 1987; 8: 305–8PubMed
159.
go back to reference Wade CE, Claybaugh JR. Plasma renin activity, vasopressin concentration and urinary excretory responses to exercise in men. J Appl Physiol 1980; 49: 930–6PubMed Wade CE, Claybaugh JR. Plasma renin activity, vasopressin concentration and urinary excretory responses to exercise in men. J Appl Physiol 1980; 49: 930–6PubMed
160.
go back to reference Reilly T, Atkinson G, Waterhouse J. Endurance performers and time-zone shifts. In: Shephard RJ, Åstrand PO, editor. Endurance in sport. Oxford: Blackwell Scientific Publications, 2000: 639–50 Reilly T, Atkinson G, Waterhouse J. Endurance performers and time-zone shifts. In: Shephard RJ, Åstrand PO, editor. Endurance in sport. Oxford: Blackwell Scientific Publications, 2000: 639–50
161.
go back to reference Korszun A, Sackett-Lundeen L, Papadopoulos E, et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26: 2675–80PubMed Korszun A, Sackett-Lundeen L, Papadopoulos E, et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26: 2675–80PubMed
162.
go back to reference Bounous G, Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses 1999; 53: 347–9PubMed Bounous G, Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses 1999; 53: 347–9PubMed
163.
go back to reference De Lorenzo F, Hargreaves J, Kakkar VV. Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad Med J 1998; 74:229–32PubMed De Lorenzo F, Hargreaves J, Kakkar VV. Phosphate diabetes in patients with chronic fatigue syndrome. Postgrad Med J 1998; 74:229–32PubMed
164.
go back to reference Durlach J, Bac P, Durlach V, et al. Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnesium Res 1997; 10: 169–95 Durlach J, Bac P, Durlach V, et al. Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance. Magnesium Res 1997; 10: 169–95
165.
go back to reference Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med 1999; 92: 183–85PubMed Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med 1999; 92: 183–85PubMed
166.
go back to reference See DM, Cimoch P, Chou S, et al. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 280–7PubMed See DM, Cimoch P, Chou S, et al. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 280–7PubMed
167.
go back to reference Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome: a case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo controlled treatment study with high doses of EFA. Acta Neurol Scand 1999; 99: 112–6PubMed Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome: a case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo controlled treatment study with high doses of EFA. Acta Neurol Scand 1999; 99: 112–6PubMed
168.
go back to reference Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 2000; 5: 93–108PubMed Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 2000; 5: 93–108PubMed
169.
go back to reference Regland B, Andersson M, Abrahamsson L, et al. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 1997; 26: 301–7PubMed Regland B, Andersson M, Abrahamsson L, et al. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 1997; 26: 301–7PubMed
170.
go back to reference Kuratsune H, Yamaguti K, Lindh G, et al. Low levels of serum acylcamitine in chronic fatigue syndrome and chronic hepatitis C, but not seen in other diseases. Int J Mol Med 1998; 2: 51–6PubMed Kuratsune H, Yamaguti K, Lindh G, et al. Low levels of serum acylcamitine in chronic fatigue syndrome and chronic hepatitis C, but not seen in other diseases. Int J Mol Med 1998; 2: 51–6PubMed
171.
go back to reference Blomstrand E, Hassmen P, Ek S, et al. Influence of ingesting a solution of branched-chain amino acids on perceived exertion during exercise. Acta Physiol Scand 1997; 159: 41–9PubMed Blomstrand E, Hassmen P, Ek S, et al. Influence of ingesting a solution of branched-chain amino acids on perceived exertion during exercise. Acta Physiol Scand 1997; 159: 41–9PubMed
172.
go back to reference Castell LM, Yamamoto T, Phoenix J, et al. The role of tryptophan in fatigue in different conditions of stress. Adv Exp Med Biol 1999; 467: 697–704PubMed Castell LM, Yamamoto T, Phoenix J, et al. The role of tryptophan in fatigue in different conditions of stress. Adv Exp Med Biol 1999; 467: 697–704PubMed
173.
go back to reference Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82: 209–16PubMed Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990; 82: 209–16PubMed
174.
go back to reference Dykman KD, Tone C, Ford C, et al. The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 61–71PubMed Dykman KD, Tone C, Ford C, et al. The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 61–71PubMed
175.
go back to reference Van Erp-Baart AMJ, Saris WMH, Binkhorst RA, et al. Nationwide survey on nutritional habits in elite athletes. Part II: mineral and vitamin intake. Int J Sports Med 1989; 10 Suppl. 1: S11–S16PubMed Van Erp-Baart AMJ, Saris WMH, Binkhorst RA, et al. Nationwide survey on nutritional habits in elite athletes. Part II: mineral and vitamin intake. Int J Sports Med 1989; 10 Suppl. 1: S11–S16PubMed
176.
go back to reference Deuster PA, Kyle SB, Moser PB, et al. Nutritional survey of highly trained women runners. Am J Clin Nutr 1986; 45: 954–62 Deuster PA, Kyle SB, Moser PB, et al. Nutritional survey of highly trained women runners. Am J Clin Nutr 1986; 45: 954–62
177.
go back to reference Loosli AR, Benson J, Gillien DM, et al. Nutrition habits and knowledge in competitive adolescent female gymnasts. Phys Sportsmed 1986; 14: 118–30 Loosli AR, Benson J, Gillien DM, et al. Nutrition habits and knowledge in competitive adolescent female gymnasts. Phys Sportsmed 1986; 14: 118–30
178.
go back to reference Moffatt RJ. Dietary status of elite female high school gymnasts: inadequacy of vitamin and mineral intake. J Am Diet Assoc 1984; 84: 1361–3PubMed Moffatt RJ. Dietary status of elite female high school gymnasts: inadequacy of vitamin and mineral intake. J Am Diet Assoc 1984; 84: 1361–3PubMed
179.
go back to reference Newsholme EA. Biochemical mechanisms to explain immunesuppression in well-trained and overtrained athletes. Int J Sports Med 1994; 15 Suppl. 3: S142–S147PubMed Newsholme EA. Biochemical mechanisms to explain immunesuppression in well-trained and overtrained athletes. Int J Sports Med 1994; 15 Suppl. 3: S142–S147PubMed
180.
go back to reference Kreider RB. Central fatigue hypothesis and overtraining. In: Kreider RB, Fry AC, O’Toole ML, editor. Overtraining in sport. Champaign (IL): Human Kinetics, 1998: 309–31 Kreider RB. Central fatigue hypothesis and overtraining. In: Kreider RB, Fry AC, O’Toole ML, editor. Overtraining in sport. Champaign (IL): Human Kinetics, 1998: 309–31
181.
go back to reference Davis JM. Carbohydrates, branch-chained amino acids, and endurance: the central fatigue hypothesis. Int J Sport Nutr 1995; 5 Suppl.: S29–S38 Davis JM. Carbohydrates, branch-chained amino acids, and endurance: the central fatigue hypothesis. Int J Sport Nutr 1995; 5 Suppl.: S29–S38
182.
go back to reference Wagenmakers AJM, Bechers EJ, Brouns F, et al. Carbohydrate supplementation, glycogen depletion, and amino acid metabolism during exercise. Am J Physiol 1991; 260: E883-E890 Wagenmakers AJM, Bechers EJ, Brouns F, et al. Carbohydrate supplementation, glycogen depletion, and amino acid metabolism during exercise. Am J Physiol 1991; 260: E883-E890
183.
go back to reference Blomstrand E, Hassmen P, Newsholme E. Effect of branchchain amino acid supplementation on mental performance. Acta Physiol Scand 1991; 143: 225–6PubMed Blomstrand E, Hassmen P, Newsholme E. Effect of branchchain amino acid supplementation on mental performance. Acta Physiol Scand 1991; 143: 225–6PubMed
184.
go back to reference Muller EE, Branbilla F, Cavagnini F, et al. Slight effect of L-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab 1974; 39: 1–4PubMed Muller EE, Branbilla F, Cavagnini F, et al. Slight effect of L-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab 1974; 39: 1–4PubMed
185.
go back to reference Teman AJ, Hairline B. Eosinophilia-myalgia syndrome: athletes should discard dietary L-tryptophan. Phys Sportsmed 1991; 19 (2): 80–82; 84; 86 Teman AJ, Hairline B. Eosinophilia-myalgia syndrome: athletes should discard dietary L-tryptophan. Phys Sportsmed 1991; 19 (2): 80–82; 84; 86
186.
go back to reference Shephard RJ, Shek PN. Heavy exercise, nutrition and immune function: is there a connection? Int J Sports Med 1995; 16:491–7PubMed Shephard RJ, Shek PN. Heavy exercise, nutrition and immune function: is there a connection? Int J Sports Med 1995; 16:491–7PubMed
187.
go back to reference Rohde T, MacLean DA, Pedersen BK. Effect of glutamine supplementation on changes in the immune system induced by repeated exercise. Med Sci Sports Exerc 1998; 30: 856–62PubMed Rohde T, MacLean DA, Pedersen BK. Effect of glutamine supplementation on changes in the immune system induced by repeated exercise. Med Sci Sports Exerc 1998; 30: 856–62PubMed
188.
go back to reference Brenner IKM, Shek PN, Shephard RJ. Infection in athletes. Sports Med 1994; 17: 86–107PubMed Brenner IKM, Shek PN, Shephard RJ. Infection in athletes. Sports Med 1994; 17: 86–107PubMed
189.
go back to reference Nieman DC. Exercise and resistance to infection. Can J Physiol Pharmacol 1998; 76: 573–80PubMed Nieman DC. Exercise and resistance to infection. Can J Physiol Pharmacol 1998; 76: 573–80PubMed
190.
go back to reference Shephard RJ, Shek PN. Infectious diseases in athletes: new interest for an old problem. J Sports Med Phys Fitness 1994; 34: 11–22PubMed Shephard RJ, Shek PN. Infectious diseases in athletes: new interest for an old problem. J Sports Med Phys Fitness 1994; 34: 11–22PubMed
191.
go back to reference Shephard RJ, Shek PN. Exercise, immunity and susceptibility to infection: a j-shaped relationship? Phys Sportsmed 1999; 27 (6): 47–71PubMed Shephard RJ, Shek PN. Exercise, immunity and susceptibility to infection: a j-shaped relationship? Phys Sportsmed 1999; 27 (6): 47–71PubMed
192.
go back to reference Gibson H, Carroll N, Clague JE, et al. Exercise performance and fatigability in patient with chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1993; 56: 993–8PubMed Gibson H, Carroll N, Clague JE, et al. Exercise performance and fatigability in patient with chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 1993; 56: 993–8PubMed
193.
go back to reference Komaroff AL. Clinic presentation of chronic fatigue syndrome. In: Bock GR, Whalan J, editors. Chronic fatigue syndrome. CIBA Foundation Symposium 173; 1992 May; London. Chichester: John Wiley, 1993: 43–61 Komaroff AL. Clinic presentation of chronic fatigue syndrome. In: Bock GR, Whalan J, editors. Chronic fatigue syndrome. CIBA Foundation Symposium 173; 1992 May; London. Chichester: John Wiley, 1993: 43–61
194.
go back to reference Meehan RT, Duncan U, Neale LS, et al. Operation Everest 2: alterations in the immune system at high altitudes. J Clin Immunol 1988; 8: 397–406PubMed Meehan RT, Duncan U, Neale LS, et al. Operation Everest 2: alterations in the immune system at high altitudes. J Clin Immunol 1988; 8: 397–406PubMed
195.
go back to reference Shephard RJ. Immune changes induced by exercise in an adverse environment. Can J Physiol Pharmacol 1998; 76: 539–46PubMed Shephard RJ. Immune changes induced by exercise in an adverse environment. Can J Physiol Pharmacol 1998; 76: 539–46PubMed
196.
go back to reference Peakman M, Deale A, Field R, et al. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82: 83–91PubMed Peakman M, Deale A, Field R, et al. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82: 83–91PubMed
197.
go back to reference Visser J, Blauw B, Hinloopen B, et al. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 1998; 177:451–4PubMed Visser J, Blauw B, Hinloopen B, et al. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 1998; 177:451–4PubMed
198.
go back to reference Vedhara K, Llewelyn MB, Fox JD, et al. Consequences of live poliovirus vaccine administration in chronic fatigue syndrome. J Neuroimmunol 1997; 75: 183–95PubMed Vedhara K, Llewelyn MB, Fox JD, et al. Consequences of live poliovirus vaccine administration in chronic fatigue syndrome. J Neuroimmunol 1997; 75: 183–95PubMed
199.
go back to reference Barker E, Fujimura SF, Fadem MB, et al. Immunological abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl. 1: S136–S141PubMed Barker E, Fujimura SF, Fadem MB, et al. Immunological abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl. 1: S136–S141PubMed
200.
go back to reference Levine PH, Whiteside TL, Friberg D, et al. Dysfunction of natural killer cell activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88: 96–104PubMed Levine PH, Whiteside TL, Friberg D, et al. Dysfunction of natural killer cell activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88: 96–104PubMed
201.
go back to reference Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105 (3A): 27S-34S Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105 (3A): 27S-34S
202.
go back to reference Ogawa M, Nishiura T, Yoshimura M, et al. Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome. Eur J Clin Invest 1998; 28: 937–43PubMed Ogawa M, Nishiura T, Yoshimura M, et al. Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome. Eur J Clin Invest 1998; 28: 937–43PubMed
203.
go back to reference Hassan IS, Bannister BA, Akbar A, et al. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol 1998; 87: 60–7PubMed Hassan IS, Bannister BA, Akbar A, et al. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol 1998; 87: 60–7PubMed
204.
go back to reference Natelson BH, LaManca JJ, Denny TN, et al. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998; 105 (3A): 43S-9S Natelson BH, LaManca JJ, Denny TN, et al. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998; 105 (3A): 43S-9S
205.
go back to reference von Mikecz A, Konstantinov K, Buchwald DS, et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40:295–305 von Mikecz A, Konstantinov K, Buchwald DS, et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40:295–305
206.
go back to reference Cannon JG, Angel JB, Abad LW et al. Interleukin-1 beta, interleukin 1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997; 17: 253–61PubMed Cannon JG, Angel JB, Abad LW et al. Interleukin-1 beta, interleukin 1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997; 17: 253–61PubMed
207.
go back to reference Cannon JG, Angel JB, Ball RW et al. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999; 19: 414–21PubMed Cannon JG, Angel JB, Ball RW et al. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999; 19: 414–21PubMed
208.
go back to reference Gupta S, Aggarwal S, See D, et al. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 149–56PubMed Gupta S, Aggarwal S, See D, et al. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997; 31: 149–56PubMed
209.
go back to reference Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314–6PubMed Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314–6PubMed
210.
go back to reference Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997; 24: 372–6PubMed Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997; 24: 372–6PubMed
211.
go back to reference Bennett AL, Chao CC, Hu S, et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160–6PubMed Bennett AL, Chao CC, Hu S, et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160–6PubMed
212.
go back to reference Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175: 136–41PubMed Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175: 136–41PubMed
213.
go back to reference LaManca JJ, Sisto SA, Zhou XD, et al. Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol 1999; 19: 135–42PubMed LaManca JJ, Sisto SA, Zhou XD, et al. Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol 1999; 19: 135–42PubMed
214.
go back to reference Shephard RJ. Physical activity, training and the immune response. Carmel (IN): Cooper Publications, 1997 Shephard RJ. Physical activity, training and the immune response. Carmel (IN): Cooper Publications, 1997
215.
go back to reference Cannon JG, Angel JB, Abad LW, et al. Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998; 18: 291–8PubMed Cannon JG, Angel JB, Abad LW, et al. Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998; 18: 291–8PubMed
216.
go back to reference Kavelaars A, Kuis W, Knook L, et al. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 692–6PubMed Kavelaars A, Kuis W, Knook L, et al. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 692–6PubMed
217.
go back to reference Vojdani A, Ghoneum M, Choppa PC, et al. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Int Med 1999; 242: 465–78 Vojdani A, Ghoneum M, Choppa PC, et al. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Int Med 1999; 242: 465–78
218.
go back to reference Vojdani A, Lapp CW. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol Immunotoxicol 1999; 21: 175–202PubMed Vojdani A, Lapp CW. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol Immunotoxicol 1999; 21: 175–202PubMed
219.
go back to reference Vojdani A, Choppa PC, Lapp CW. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2–5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 1998; 50: 1–16PubMed Vojdani A, Choppa PC, Lapp CW. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2–5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J Clin Lab Immunol 1998; 50: 1–16PubMed
220.
go back to reference Conti F, Pittoni V, Sacerdote P, et al. Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol 1998; 16:729–32PubMed Conti F, Pittoni V, Sacerdote P, et al. Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol 1998; 16:729–32PubMed
221.
go back to reference Shek PN, Shephard RJ. Physical exercise as a human model of limited inflammatory response. Can J Physiol Pharmacol 1998; 76: 589–97PubMed Shek PN, Shephard RJ. Physical exercise as a human model of limited inflammatory response. Can J Physiol Pharmacol 1998; 76: 589–97PubMed
222.
go back to reference Natelson BH, Denny T, Zhou XD, et al. Is depression associated with immune activation? J Affect Disord 1999; 53: 179–84PubMed Natelson BH, Denny T, Zhou XD, et al. Is depression associated with immune activation? J Affect Disord 1999; 53: 179–84PubMed
223.
go back to reference Moldoveanu AL, Shepard RJ, Slick PN. The physical response to physical activity and training. Sports Med 2001; 31 (2): 115–44PubMed Moldoveanu AL, Shepard RJ, Slick PN. The physical response to physical activity and training. Sports Med 2001; 31 (2): 115–44PubMed
224.
go back to reference Vollmer-Conna U, Lloyd A, Hickie I, et al. Chronic fatigue syndrome: An immunological perspective. Austr N Z J Psychiatr 1998; 32: 523–7 Vollmer-Conna U, Lloyd A, Hickie I, et al. Chronic fatigue syndrome: An immunological perspective. Austr N Z J Psychiatr 1998; 32: 523–7
225.
go back to reference Penttila IA, Harris RJ, Storm P, et al. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q J Med 1998; 91: 549–60 Penttila IA, Harris RJ, Storm P, et al. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q J Med 1998; 91: 549–60
226.
go back to reference Gupta S, Aggarwal S, Starr A. Increased production of interleukin 6 by adherent and non-adherent mononuclear cells during ‘natural fatigue’ but not following ‘experimental fatigue’ in patients with chronic fatigue syndrome. Int J Mol Med 1999; 3: 209–13PubMed Gupta S, Aggarwal S, Starr A. Increased production of interleukin 6 by adherent and non-adherent mononuclear cells during ‘natural fatigue’ but not following ‘experimental fatigue’ in patients with chronic fatigue syndrome. Int J Mol Med 1999; 3: 209–13PubMed
227.
go back to reference Gannon GA, Rhind S, Shek PN, et al. Circulating levels of peripheral blood leukocytes and cytokines following competitive cycling. Can J Appl Physiol 1997; 22: 133–47PubMed Gannon GA, Rhind S, Shek PN, et al. Circulating levels of peripheral blood leukocytes and cytokines following competitive cycling. Can J Appl Physiol 1997; 22: 133–47PubMed
228.
go back to reference Richardson MT, Schuler PB, Westerfield RC, et al. Cytokine response to submaximal exercise in chronic fatigue immune dysfunction syndrome patients and sedentary controls [abstract]. Med Sci Sports Exerc 1994; 26: S47 Richardson MT, Schuler PB, Westerfield RC, et al. Cytokine response to submaximal exercise in chronic fatigue immune dysfunction syndrome patients and sedentary controls [abstract]. Med Sci Sports Exerc 1994; 26: S47
229.
go back to reference Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gamma globulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 1997; 31: 133–47PubMed Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gamma globulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 1997; 31: 133–47PubMed
230.
go back to reference Vollmer-Conna U, Hickie I, Hadzi-Pavlovie D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997;103:38–43PubMed Vollmer-Conna U, Hickie I, Hadzi-Pavlovie D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997;103:38–43PubMed
231.
go back to reference Plioplys AV. Antimuscle and anti-CNS circulating antibodies in chronic fatigue syndrome. Neurology 1997; 48: 1717–9PubMed Plioplys AV. Antimuscle and anti-CNS circulating antibodies in chronic fatigue syndrome. Neurology 1997; 48: 1717–9PubMed
232.
go back to reference Krilov LR, Fisher M, Friedman SB, et al. Course and outcome of chronic fatigue in children and adolescents. Pediatrics 1998; 102 (2 Pt 1): 360–6PubMed Krilov LR, Fisher M, Friedman SB, et al. Course and outcome of chronic fatigue in children and adolescents. Pediatrics 1998; 102 (2 Pt 1): 360–6PubMed
233.
go back to reference Borish L, Schmaling K, DiClementi JD, et al. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychological variables. J Allerg Clin Immunol 1998; 102: 222–30 Borish L, Schmaling K, DiClementi JD, et al. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychological variables. J Allerg Clin Immunol 1998; 102: 222–30
234.
go back to reference Hall GH, Hamilton WT, Round AP Increased illness experience preceding chronic fatigue syndrome: a case-control study. J R Coll Phys (Lond) 1998; 32: 44–8 Hall GH, Hamilton WT, Round AP Increased illness experience preceding chronic fatigue syndrome: a case-control study. J R Coll Phys (Lond) 1998; 32: 44–8
235.
go back to reference Endicott NA. Chronic fatigue syndrome in psychiatric patients: lifetime and premorbid personal history of physical health. Psychosom Med 1998; 60: 744–51PubMed Endicott NA. Chronic fatigue syndrome in psychiatric patients: lifetime and premorbid personal history of physical health. Psychosom Med 1998; 60: 744–51PubMed
236.
go back to reference Fukuda K, Dobbins JG, Wilson LJ, et al. An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. J Psychiatr Res 1997; 31: 19–29PubMed Fukuda K, Dobbins JG, Wilson LJ, et al. An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. J Psychiatr Res 1997; 31: 19–29PubMed
237.
238.
go back to reference Nakaya T, Kuratsune H, Kitani T, et al. Demonstration of Borna disease virus in patients with chronic fatigue syndrome. Jap J Clin Med 1997; 55: 3064–71 Nakaya T, Kuratsune H, Kitani T, et al. Demonstration of Borna disease virus in patients with chronic fatigue syndrome. Jap J Clin Med 1997; 55: 3064–71
239.
go back to reference Nakaya T, Takahashi H, Nakamur Y, et al. Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome. Microbiol Immunol 1999; 43: 679–89PubMed Nakaya T, Takahashi H, Nakamur Y, et al. Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome. Microbiol Immunol 1999; 43: 679–89PubMed
240.
go back to reference Levine PH, Fears TR, Cummings P, et al. Cancer and fatiguing illness in Northern Nevada: a causal hypothesis. Ann Epidemiol 1998; 8: 245–9PubMed Levine PH, Fears TR, Cummings P, et al. Cancer and fatiguing illness in Northern Nevada: a causal hypothesis. Ann Epidemiol 1998; 8: 245–9PubMed
241.
go back to reference Garcia-Borreguero D, Dale JK, Rosenthal NE, et al. Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome. Psychiatr Res 1998; 77: 71–7 Garcia-Borreguero D, Dale JK, Rosenthal NE, et al. Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome. Psychiatr Res 1998; 77: 71–7
242.
go back to reference Levine PH, Snow PG, Ranum BA, et al. Epidemiologic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Arch Int Med 1997; 157: 750–4 Levine PH, Snow PG, Ranum BA, et al. Epidemiologic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Arch Int Med 1997; 157: 750–4
243.
go back to reference Kubo K, Fujiyoshi T, Yokoyama MM, et al. Lack of association of Borna disease virus and human T-cell leukemia virus type I infections with psychiatric disorders among Japanese patients. Clin Diagn Lab Immunol 1997; 4: 189–94PubMed Kubo K, Fujiyoshi T, Yokoyama MM, et al. Lack of association of Borna disease virus and human T-cell leukemia virus type I infections with psychiatric disorders among Japanese patients. Clin Diagn Lab Immunol 1997; 4: 189–94PubMed
244.
go back to reference Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 1994; 42: 42–6PubMed Natelson BH, Ye N, Moul DE, et al. High titers of anti-Epstein Barr virus DNA polymerase are found in patients with severe fatiguing illness. J Med Virol 1994; 42: 42–6PubMed
245.
go back to reference Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active herpes virus type 6 infection. Ann Intern Med 1992; 116: 103–13PubMed Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active herpes virus type 6 infection. Ann Intern Med 1992; 116: 103–13PubMed
246.
go back to reference Cuende JI, Civeira P, Diez N, et al. High prevalence without reactivation of herpes virus 6 in subjects with chronic fatigue syndrome [in Spanish]. An Med Interna 1997; 14: 441–4PubMed Cuende JI, Civeira P, Diez N, et al. High prevalence without reactivation of herpes virus 6 in subjects with chronic fatigue syndrome [in Spanish]. An Med Interna 1997; 14: 441–4PubMed
247.
go back to reference Swanink CM, Stolk-Engelaar VM, van der Meer JW, et al. Yersinia enterocolitica and the chronic fatigue syndrome. J Infect 1998; 36: 269–72PubMed Swanink CM, Stolk-Engelaar VM, van der Meer JW, et al. Yersinia enterocolitica and the chronic fatigue syndrome. J Infect 1998; 36: 269–72PubMed
248.
go back to reference Bruno RL, Creange SJ, Frick NM. Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology? Am J Med 1998; 105 (3A): 66S-73S Bruno RL, Creange SJ, Frick NM. Parallels between post-polio fatigue and chronic fatigue syndrome: a common pathophysiology? Am J Med 1998; 105 (3A): 66S-73S
249.
go back to reference Morag M, Morag A, Reichenberg A, et al. Psychological variables as predictors of rubella antibody titers and fatigue: a prospective double-blind study. J Psychiatr Res 1999; 33: 389–95PubMed Morag M, Morag A, Reichenberg A, et al. Psychological variables as predictors of rubella antibody titers and fatigue: a prospective double-blind study. J Psychiatr Res 1999; 33: 389–95PubMed
250.
go back to reference Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syndrome following Q fever. Q J Med 1998; 91: 105–23 Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syndrome following Q fever. Q J Med 1998; 91: 105–23
251.
go back to reference Treib J, Grauer MT, Haass A, et al. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur Neurol 2000; 43: 107–9PubMed Treib J, Grauer MT, Haass A, et al. Chronic fatigue syndrome in patients with Lyme borreliosis. Eur Neurol 2000; 43: 107–9PubMed
252.
go back to reference Ottenweller JE, Natelson BH, Gause WC, et al. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study fatigue. Physiol Behav 1998; 63: 795–801PubMed Ottenweller JE, Natelson BH, Gause WC, et al. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study fatigue. Physiol Behav 1998; 63: 795–801PubMed
253.
go back to reference Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18: 859–65PubMed Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18: 859–65PubMed
254.
go back to reference Vojdani A, Choppa PC, Tagle C, et al. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998; 22: 355–65PubMed Vojdani A, Choppa PC, Tagle C, et al. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998; 22: 355–65PubMed
255.
go back to reference Roberts JA. Viral illnesses and sports performance. Sports Med 1986; 3: 296–303 Roberts JA. Viral illnesses and sports performance. Sports Med 1986; 3: 296–303
256.
go back to reference Cruchley AT, Williams DT, Nidobitek G, et al. Epstein-Barn virus: biology and disease. Oral Dis 1997; 3 Suppl. 1: S156–S163PubMed Cruchley AT, Williams DT, Nidobitek G, et al. Epstein-Barn virus: biology and disease. Oral Dis 1997; 3 Suppl. 1: S156–S163PubMed
257.
go back to reference DeWaal Malewfyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–24 DeWaal Malewfyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–24
258.
go back to reference Whittingham S, Naselli G, Harrison LC, et al. Cytokine production in response to Epstein-Barn virus infection of peripheral blood mononuclear cells in vitro. Immunol Cell Biol 1993; 71: 259–64PubMed Whittingham S, Naselli G, Harrison LC, et al. Cytokine production in response to Epstein-Barn virus infection of peripheral blood mononuclear cells in vitro. Immunol Cell Biol 1993; 71: 259–64PubMed
259.
go back to reference Bourgault I, Gomez A, Gomard E, et al. Limiting-dilution analysis of the HLA-restriction of anti-Epstein-Barr virus-specific cytotoxic T lymphocytes. Clin Exp Immunol 1991; 84: 501–7PubMed Bourgault I, Gomez A, Gomard E, et al. Limiting-dilution analysis of the HLA-restriction of anti-Epstein-Barr virus-specific cytotoxic T lymphocytes. Clin Exp Immunol 1991; 84: 501–7PubMed
260.
go back to reference Gleeson M, Koina C, Clancy RL, et al. Epstein-Barr virus reactivation in elite swimmers. In: International Society for Exercise and Immunology. 4th Symposium; 1999 May 21–23; Rome. Int J Sports Med 2000; 21 Suppl. 1: S83 Gleeson M, Koina C, Clancy RL, et al. Epstein-Barr virus reactivation in elite swimmers. In: International Society for Exercise and Immunology. 4th Symposium; 1999 May 21–23; Rome. Int J Sports Med 2000; 21 Suppl. 1: S83
261.
go back to reference White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatr 1998; 173: 475–81 White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatr 1998; 173: 475–81
262.
go back to reference Wallace HL, Natelson B, Gause W, et al. Human herpes viruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 216–23PubMed Wallace HL, Natelson B, Gause W, et al. Human herpes viruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 216–23PubMed
263.
go back to reference Bosenberg AT, Brock-Utne JG, Gaffin SL, et al. Strenuous exercise causes systemic endotoxemia. J Appl Physiol 1988; 65: 106–8PubMed Bosenberg AT, Brock-Utne JG, Gaffin SL, et al. Strenuous exercise causes systemic endotoxemia. J Appl Physiol 1988; 65: 106–8PubMed
264.
go back to reference Feldman RM, Soskolne CL. The use of non-fatiguing strengthening exercises in post-polio syndrome. Birth Defects Orig Antic Ser 1987; 23: 335–41 Feldman RM, Soskolne CL. The use of non-fatiguing strengthening exercises in post-polio syndrome. Birth Defects Orig Antic Ser 1987; 23: 335–41
265.
go back to reference Evengard B, Briese T, Lindh G, et al. Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome. J Neurovirol 1999; 5: 495–9PubMed Evengard B, Briese T, Lindh G, et al. Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome. J Neurovirol 1999; 5: 495–9PubMed
266.
go back to reference Elkins LE, Pollina DA, Scheffer SR, et al. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 1999; 6: 19–26PubMed Elkins LE, Pollina DA, Scheffer SR, et al. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 1999; 6: 19–26PubMed
267.
go back to reference Gaudino EA, Coyle PK, Krupp LB. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol 1997; 54: 1372–6PubMed Gaudino EA, Coyle PK, Krupp LB. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol 1997; 54: 1372–6PubMed
268.
go back to reference Schutzer SE, Natelson BH. Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome. Neurology 1999; 53: 1340–1PubMed Schutzer SE, Natelson BH. Absence of Borrelia burgdorferi-specific immune complexes in chronic fatigue syndrome. Neurology 1999; 53: 1340–1PubMed
269.
go back to reference Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J Neurol Neurosurg Psychiatr 1996; 60: 504–9PubMed Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. J Neurol Neurosurg Psychiatr 1996; 60: 504–9PubMed
270.
go back to reference Imboden J, Canter A, Cluff L. Convalescence from influenza: a study of the psychological and clinical determinants. Arch Int Med 1961; 108: 393–9 Imboden J, Canter A, Cluff L. Convalescence from influenza: a study of the psychological and clinical determinants. Arch Int Med 1961; 108: 393–9
271.
go back to reference White P, Grover S, Kangro H, et al. The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol Med 1995; 25: 917–24PubMed White P, Grover S, Kangro H, et al. The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol Med 1995; 25: 917–24PubMed
272.
go back to reference Bombardier CH, Buchwald D. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome. Arch Int Med 1995; 155: 2105–10 Bombardier CH, Buchwald D. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome. Arch Int Med 1995; 155: 2105–10
273.
go back to reference Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997; 90: 223–33 Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997; 90: 223–33
274.
go back to reference Hill NF, Tioersky LA, Scavalla VR, et al. Natural history of severe chronic fatigue syndrome. Arch Phys Med Rehabil 1999; 80: 1090–4PubMed Hill NF, Tioersky LA, Scavalla VR, et al. Natural history of severe chronic fatigue syndrome. Arch Phys Med Rehabil 1999; 80: 1090–4PubMed
275.
go back to reference Rangel L, Garralda ME, Levin M, et al. The course of severe chronic fatigue syndrome in childhood. J R Soc Med 2000; 93: 129–34PubMed Rangel L, Garralda ME, Levin M, et al. The course of severe chronic fatigue syndrome in childhood. J R Soc Med 2000; 93: 129–34PubMed
276.
go back to reference Pheley AM, Melby D, Schenck C, et al. Can we predict recovery in chronic fatigue syndrome? Minn Med 1999; 82: 52–6PubMed Pheley AM, Melby D, Schenck C, et al. Can we predict recovery in chronic fatigue syndrome? Minn Med 1999; 82: 52–6PubMed
277.
go back to reference Miro O, Font C, Fernandez-Sola J, et al. Chronic fatigue syndrome: study of the clinical course of 28 cases. Med Clin (Barc) 1997; 108: 561–5 Miro O, Font C, Fernandez-Sola J, et al. Chronic fatigue syndrome: study of the clinical course of 28 cases. Med Clin (Barc) 1997; 108: 561–5
278.
go back to reference Stark FM, Sobetzko HM. Approaches to coping with chronic fatigue syndrome (CFS). Zentralbl Hyg Umweltmed 1999; 202: 179–90PubMed Stark FM, Sobetzko HM. Approaches to coping with chronic fatigue syndrome (CFS). Zentralbl Hyg Umweltmed 1999; 202: 179–90PubMed
279.
go back to reference de Jong LW, Prins JB, Fischer TJ, et al. Chronic fatigue syndrome in young persons. Ned Tijdschr Geneeskd 1997; 141: 1513–6PubMed de Jong LW, Prins JB, Fischer TJ, et al. Chronic fatigue syndrome in young persons. Ned Tijdschr Geneeskd 1997; 141: 1513–6PubMed
280.
go back to reference Sharpe M, Chalder T, Palmer I, et al. Chronic fatigue syndrome: a practical guide to assessment and management. Gen Hosp Psychiatr 1997; 19: 185–99 Sharpe M, Chalder T, Palmer I, et al. Chronic fatigue syndrome: a practical guide to assessment and management. Gen Hosp Psychiatr 1997; 19: 185–99
281.
go back to reference van den Meer JW, Rijken PM, Bleijenberg G, et al. Indications for management in long-tern, physically unexplained fatigue syndrome. Ned Tijdschr Geneeskd 1997; 141: 1516–9PubMed van den Meer JW, Rijken PM, Bleijenberg G, et al. Indications for management in long-tern, physically unexplained fatigue syndrome. Ned Tijdschr Geneeskd 1997; 141: 1516–9PubMed
282.
go back to reference Lawrie SM, Pelosi AJ. Chronic fatigue syndrome: prevalence and outcomes. BMJ 1994; 308: 732–3PubMed Lawrie SM, Pelosi AJ. Chronic fatigue syndrome: prevalence and outcomes. BMJ 1994; 308: 732–3PubMed
283.
go back to reference Russo J, Karen W, Clark M, et al. Longitudinal changes associated with improvement in chronic fatigue patients. J Psychosom Res 1998; 45: 67–76PubMed Russo J, Karen W, Clark M, et al. Longitudinal changes associated with improvement in chronic fatigue patients. J Psychosom Res 1998; 45: 67–76PubMed
284.
go back to reference Jason LA, Melrose H, Lerman A, et al. Managing chronic fatigue syndrome: overview and case study. Am Assoc Occup Health Nurses J 1999; 47: 17–21 Jason LA, Melrose H, Lerman A, et al. Managing chronic fatigue syndrome: overview and case study. Am Assoc Occup Health Nurses J 1999; 47: 17–21
285.
go back to reference Marlin RG, Anchel H, Gibson JC, et al. An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. Am J Med 1998; 105 (3A): 110S-4S Marlin RG, Anchel H, Gibson JC, et al. An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. Am J Med 1998; 105 (3A): 110S-4S
286.
go back to reference Jason LA, King CP, Frankenberry EL, et al. Chronic fatigue syndrome: assessing symptoms and activity level. J Clin Psychol 1999; 55: 411–24PubMed Jason LA, King CP, Frankenberry EL, et al. Chronic fatigue syndrome: assessing symptoms and activity level. J Clin Psychol 1999; 55: 411–24PubMed
287.
go back to reference Young M. How I treat return to sport after post-viral fatigue. Br J Sports Med 1999; 33: 173PubMed Young M. How I treat return to sport after post-viral fatigue. Br J Sports Med 1999; 33: 173PubMed
288.
go back to reference Greenslade RA. Presumed infectious mononucleosis in a college basketball player. Phys Sportsmed 2000; 28 (6): 79–86PubMed Greenslade RA. Presumed infectious mononucleosis in a college basketball player. Phys Sportsmed 2000; 28 (6): 79–86PubMed
289.
go back to reference Wearden AJ, Morris RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatr 1998; 172: 485–90 Wearden AJ, Morris RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatr 1998; 172: 485–90
290.
go back to reference Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997; 314: 1647–52PubMed Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997; 314: 1647–52PubMed
291.
go back to reference Shepherd C, Macintyre A. Patients should have initial period of rest before gradual increase in activity [letter]. BMJ 1997; 315: 947PubMed Shepherd C, Macintyre A. Patients should have initial period of rest before gradual increase in activity [letter]. BMJ 1997; 315: 947PubMed
292.
go back to reference Franklin AJ. Including persons who rated themselves as a little better would have altered results [letter]. BMJ 1997; 315: 947PubMed Franklin AJ. Including persons who rated themselves as a little better would have altered results [letter]. BMJ 1997; 315: 947PubMed
293.
go back to reference Sadler M. Patients were a selected group [letter]. BMJ 1997; 315: 947–8PubMed Sadler M. Patients were a selected group [letter]. BMJ 1997; 315: 947–8PubMed
Metadata
Title
Chronic Fatigue Syndrome
An Update
Author
Professor Roy J. Shephard
Publication date
01-03-2001
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 3/2001
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.2165/00007256-200131030-00003

Other articles of this Issue 3/2001

Sports Medicine 3/2001 Go to the issue